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To apply cDNA-RNA hybridization methods to the detection of hepatitis A virus (HAV) in clinical materials,
we developed a two-step method in which a microtiter-based, solid-phase immunoadsorption procedure
incorporating a monoclonal anti-HAV capture antibody was followed by direct blotting of virus eluates to
nitrocellulose and hybridization with 32P-labeled recombinant HAV cDNA. This immunoaffinity hybridization
method is simple and involves few sample manipulations, yet it retains high sensitivity (10- to 30-fold more than
radioimmunoassay) and is capable of detecting approximately 1 x l0e to 2 x l0e genome copies of virus. The
inclusion of the immunoaffinity step removes most contaminating proteins and thus facilitates subsequent
immobilization of the virus for hybridization. It aiso permits positive hybridization signals to be related to
specific antigens and adds a level of specificity to the hybridization procedure. When the method was applied
to 23 fecal specimens collected from individuals during week 1 of symptoms due to hepatitis A, 13 specimens
were found to be reproducibly positive for HAV RNA by immunoaffinity hybridization, whereas only Il
contained viral antigen detectable by radioimmunoassay.
Wild-type hepatitis A virus (HAV) grows only poorly in
cell culture, and primary isolation of the virus is slow and
unpredictable (3, 20). Other methods, such as immune
electron microscopy (8) or solid-phase immunoassays (22),
have therefore been used for the detection ofHAV in clinical
specimens or in specimens collected from experimentally
infected nonhuman primates. Compared with these older
immunologically based methods for detection of the virus,
the recent application of cDNA-RNA hybridization by using
32P-labeled recombinant cDNA probes appears to offer en-
hanced sensitivity (21). However, this potential advantage
may be offset by the presence in crude fecal suspensions of
contaminating nucleic acids or proteins that may result in
false-positive hybridization signals (1, 5). Even the use of
highly purified cDNA insert probes may not totally over-
come this limitation, which is not restricted to the HAV
system (1). In addition, the preparation ofRNA contained in
clinical specimens for hybridization may involve several
steps, including denaturation and protease digestion of pro-
teins followed by chemical extraction of viral RNA (21), and
thus often entails multiple manipulations of each specimen.
This makes the procedure difficult to apply to many samples
and is an additional factor hindering the application of
hybridization techniques to clinical materials.
We avoided the problems inherent in cDNA-RNA hybrid-
ization of grossly contaminated clinical specimens, such as
fecal suspensions, by the incorporation of a simple solid-
phase immunoadsorption procedure before the immobiliza-
tion of viral RNA on nitrocellulose paper. The technical
simplicity of this procedure is further enhanced by the fact
that HAV, when suspended in a medium with low protein
content, may be blotted directly onto nitrocellulose paper,
without prior protease digestion or extraction with organic
solvents, and subsequently is detected by cDNA-RNA hy-
bridization without loss of sensitivity. In this paper, we
describe this combined immunoaffinity hybridization ap-
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proach to the detection ofHAV and its application to human
fecal specimens.
MATERIALS AND METHODS
HAV. Cell culture-adapted HAV was purified from infected
BS-C-1 cell culture supernatant fluids by polyethylene glycol
precipitation and repetitive isopycnic and rate-zonal ultra-
centrifugation, as described previously (14).
Antibody. Monoclonal antibody to HAV was the generous
gift of A. G. Coulepis and I. D. Gust, Fairfield Hospital,
Melbourne, Australia (17). Monoclonal antibody to
mycoplasma attachment protein was obtained from P.-C.
Hu, University of North Carolina School of Medicine,
Chapel Hill, and was used as a specificity control.
Clinical material. Fecal samples were obtained from New
World owl monkeys (11) and human volunteers (4) undergo-
ing experimental infection with HAV, as well as from
individuals involved in natural outbreaks of hepatitis A
occurring in Kansas and the Federal Republic of Germany
(10). Fecal specimens were tested as 10 to 20% suspensions
made in normal saline or Hanks balanced salt solution and
clarified at 7,000 x g for 30 min.
RNA extractions. Total cellular RNA was extracted from
normal and HAV-infected BS-C-1 cells by the guanidinium
thiocyanate-cesium chloride method (18). Virion RNA was
obtained by treatment of gradient-purified HAV with pro-
teinase K and sodium dodecyl sulfate (SDS), followed by
phenol-chloroform extraction and ethanol precipitation (25).
For the extraction of RNA from fecal suspensions, samples
were subjected to i% SDS and proteinase K digestion for 30
min at 37°C, followed by extraction with phenol-chloroform
and subsequent blotting to nitrocellulose.
Solid-phase immunoaffinity purification of HAV for hybrid-
ization. Individual wells of polyvinyl chloride "U" bottom
microtiter plates (Dynatech Laboratories, Inc., Alexandria,
Va.) were coated with 100 pl of murine ascitic fluid (K3-2F2)
containing monoclonal antibody to HAV (17) diluted 1:1,000
in 50 mM sodium carbonate buffer (pH 9.6). After 4 h of
incubation at 37°C, 100 ,ul of 1% bovine serum albumin, also
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diluted in carbonate buffer, was added to each well, and the
microtiter plates were incubated for an additional hour at
37°C. The microtiter wells were then washed twice with
phosphate-buffered saline containing 0.05% Tween 80 and
loaded with samples (50 to 100 pil) of tissue culture fluids,
gradient fractions, or fecal suspensions containing HAV.
After an overnight incubation at 4°C, the wells were washed
three times with phosphate-buffered saline, and the virus
bound to the solid-phase support was eluted by the addition
of 100 pul of 0.1 N HCL. After 30 min at room temperature,
the eluate was aspirated from the wells and applied directly
to nitrocellulose for hybridization as described below.
Blotting of HAV to nitrocellulose paper. RNA extracts
were diluted with 3 volumes of 10 x SSC (1 x SSC is 0.15 M
NaCl plus 0.015 M sodium citrate) in 6.15 M formaldehyde
(G. Wahl, "Sequences" application update 371, Schleicher
& Schuell, Inc., Keene, N.H.) and were heated before being
blotted for 15 min at 65°C. For blotting of whole-virus
samples, specimens were diluted into either 500 of 7.5 x
SSC in 4.6 M formaldehyde (blotting buffer, for samples of
50 or less) or 3 volumes of 10 x SSC in 6.15 M
formaldehyde (for all other whole-virus samples, including
HCl-released immunoaffinity eluates). Blotting consisted of
direct application to BA85 nitrocellulose paper (Schleicher
& Schuell) in the Minifold Il slot blotter (Schleicher &
Schuell), followed by one wash with 10 x SSC. After air
drying for at least 30 min, the nitrocellulose papers were
baked at 80°C in a vacuum oven for at least 2 h.
HAV cDNA probes. Escherichia coli cultures containing
recombinant pBR322 plasmids pHAVLB1307, pHAVLB148,
and pHAVLB228 which contain inserts of cDNA comple-
mentary to portions of wild-type (6th marmoset passage)
HM-175 strain virion RNA were obtained from J. R.
Ticehurst of the National Institute of Allergy and Infectious
Diseases, Bethesda, Md. (25). After large-scale culture
growth and plasmid amplification by standard procedures
(18), plasmid DNA was isolated from lysed E. coli cultures
by repetitive banding in CsCl-ethidium bromide gradients.
HAV cDNA inserts were excised from plasmid DNA by
digestion with PstI, electrophoretically separated from
pBR322 DNA in a low-melting-point agarose gel (Bethesda
Research Laboratories, Inc., Gaithersburg, Md.), and recov-
ered as previously described (7). Three different probes were
used for most of the described work. These included probe
1307-2 (approximately 700 bases long, derived from the 5'
end of the HAV genome, and extending approximately 44
bases into the putative VP2 coding sequence), probe 1307-1
(approximately 1,900 bases long, starting 152 bases 3' of
probe 1307-2 and spanning most of the putative capsid
sequence region), and probe 228 (approximately 2,200 bases
long and spanning the central portion of the genome) (2, 25).
32P-labeled probes were prepared from purified insert DNA
by partial denaturation followed by random priming with calf
thymus oligodeoxynucleotide fragments and E. coli DNA
polymerase I (24). Labeled DNA was precipitated with
ethanol, dissolved in water, and used directly in the hybrid-
ization assay described below.
cDNA-RNA hybridization. Nitrocellulose papers were
prehybridized for at least 3 h at 42°C in a solution containing
50% formamide (MCB Manufacturing Chemists Inc.,
Darmstadt, Federal Republic of Germany), 2.5 x Denhardt
solution, 5 x SSC, 0.1% SDS, and denatured calf thymus
DNA at 100 ,ug/ml. For hybridization, the prehybridization
solution was replaced with a similar solution containing only
1 x Denhardt solution and 32P-labeled probe at a concentra-
tion of 0.5 x 106 to 2.5 x 106 cpm/ml. The probe was boiled
for 3 min immediately before dilution into hybridization
solutions. Hybridization was performed at 42°C in the pres-
ence of 50% formamide with gentle shaking for at least 22 h.
The nitrocellulose was washed twice with 2 x SSC-0. 1%
SDS at room temperature for 15 to 30 min per wash and
twice with 0.1 x SSC-0.1% SDS at 52°C for 20 to 30 min per
wash. After brief blotting on Whatman 3MM filter paper, the
nitrocellulose papers were sealed in plastic wrap and placed
in film cassettes containing Kodak XAR-5 film (Eastman
Kodak Co., Rochester, N.Y.) and Kodak X-Omatic intensi-
fying screens. The films were developed after exposure for
16 h to 8 days at -70°C. The intensity of hybridization
signals was assessed by laser densitometry with an LKB
Ultroscan (LKB Instruments, Turku, Finland).
Solid-phase radioimmunoassay for HAV. HAV antigen was
detected in fecal suspensions and gradient fractions by a
solid-phase radioimmunoassay described previously (15).
A positive result was defined in this assay by a speci-
men/control cpm ratio of 2.1 or greater and was considered
specific for HAV in fecal specimens only if positive results
were competitively blocked 50% or more after the addition
of convalescent chimpanzee serum to the radiolabeled de-
tector antibody. When noted, monoclonal anti-HAV murine
ascitic fluid (17), diluted 1:1,000 in carbonate buffer, re-
placed the polyclonal capture antibody normally used in this
assay.
RESULTS
cDNA-RNA hybridization after direct blotting of intact
HAV. In an attempt to bypass protease and detergent
treatments and phenol-chloroform extractions for the prep-
aration of HAV RNA, we blotted suspensions of purified
virions directly onto nitrocellulose. Purified virion suspen-
sions (14) (either untreated or treated with various combina-
tions of proteinase K digestion and SDS denaturation),
diluted into 7.5 x SSC-4.6 M formaldehyde blotting buffer
and applied directly to nitrocellulose, gave a positive hybrid-
ization signal. The intensity of this signal was not enhanced
by prior treatment of the virus with either proteinase K or
SDS (data not shown). To compare the sensitivity of direct
blotting of virus with blotting of RNA prepared by a protein-
àse K-SDS-phenol-chloroform extraction procedure (25),
both methods were applied to a series of dilutions made from
sucrose gradient-purified virus (Fig. 1, lanes A and C) and a
positive human fecal specimen (Fig. 1, lanes D and F). In
several different experiments, direct blotting of virus proved
3 to 30 times more sensitive than blotting of extracted RNA
in terms of the highest sample dilution yielding a positive
hybridization signal. The lower ratio, 3, was obtained when
1 mM aurintricarboxylic acid, a potent RNase inhibitor, was
included in the RNA extraction mixture. Incubation of
whole-virus blots with RNase after the baking of the nitro-
cellulose paper but before the prehybridization step elimi-
nated the positive hybridization signal, indicating that immo-
bilized 32P was due to cDNA-RNA hybridization and not to
nonspecific binding or trapping of probe by viral or other
proteins (data not shown). By quantitatively comparing blot
intensities obtained when probe 1307-2 was hybridized in the
same experiment against a known quantity of purified plas-
mid pHAVLB113 DNA (containing sequences identical to
those in the probe) (25), the minimal quantity of virus
detectable with the direct blot method was estimated to be 1
x 105 to 2 x 105 HAV genome copies, or less than 5 x 103
radioimmunofocus-forming units of virus (12).
Immunoaffinity hybridization. Whereas direct blotting pro-
vides a simple and efficient means of detecting HAV in cell
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FIG. 1. Comparison of different methods for the detection of
HAV RNA in a gradient-purified, cell culture-adapted virus prepa-
ration (lanes A to C) and a representative virus-positive fecal
specimen (GR8 [Tables 2 and 3]; lanes D to F). Indicated dilutions
were prepared for both samples and then subjected to direct blotting
(lanes A and D), immunoaffinity hybridization (lanes B and E), or
RNA extraction followed by RNA blotting (lanes C and F). The
probe was 1307-1; autoradiographs were exposed for 72 h. Undi-
luted gradient-purified virus was estimated to contain 4 x 109
genome copies per ml, and the 20% GR8 fecal suspension contained
about 4 x 108 genome copies per ml (based on a comparison with
purified plasmid DNA).
culture supernatant fluids and gradient fractions, its applica-
tion to the detection of viral RNA in fecal suspensions is not
practical. In concentrated fecal suspensions (20%), contam-
inating proteins and other debris frequently clog the pores of
the nitrocellulose paper to such a degree that sample flow is
substantially impeded (see below). Moreover, the binding of
probe to extraneous proteins and nucleic acids (possibly
including common DNA vector sequences) may lead to
false-positive hybridization signals (1, 5). These problems
were eliminated by the introduction of a simple solid-phase
immunoaffinity purification step which removed contaminat-
ing materials before blotting. The wells of plastic tnicrotiter
plates were coated with monoclonal antibody to HAV (17) at
a dilution that was determined to be optimal, and the
resulting solid-phase immunoadsorbent was used to bind the
virus present in clinical specimens. (In preliminary experi-
ments with a solid-phase radioimmunoassay, we had con-
firmed that this monoclonal antibody [K3-2F2] was broadly
reactive against several HAV strains and capable of effi-
ciently binding the HM-175, PA-21, GR-8, LV-374, and
MS-1 strains of the virus.)
Several different elution buffers or denaturing solutions
were assessed for their ability to remove virus bound to the
antibody-coated solid phase (Table 1). The efficiency of each
elution buffer was assessed by direct blotting of the eluate
(diluted 10-fold in blotting buffer) to nitrocellulose, followed
by hybridization with the HAV cDNA probe, and by react-
ing the residual virus remaining bound to the solid-phase
with 1251-anti-HAV (13). The strongest hybridization signals
were achieved when virus was eluted with 1% SDS or 0.1 N
HCI, although 0.1 N HCl resulted in more complete removal
of virus from the solid phase. Blot intensities achieved after
immunoaffinity purification of the virus and elution with 1%
SDS or 0.1 N HCl were somewhat greater than those
achieved with direct blotting of the virus suspension, and
this may reflect the removal of 0.1% bovine serum albumin
present in the original virus diluent. Because 0.1 N HCl
resulted in more consistent hybridization signals than the use
of 1% SDS, 0.1 N HCI was used in subsequent experiments.
However, preliminary results suggested that 1% SDS might
TABLE 1. Efficiency of various buffers in eluting HAV in the
solid-phase immunoadsorption procedure
Residual boundElution Blot intensity antigen (cpm)
buffer (%)ni (%)b
5% TCAC 0 (0) 112 (3)
1 N HCl 0 (0) 72 (2)
0.1 N HCI 1,147 (145) 202 (5)
4 M Urea 410 (52) 2,201 (54)
0.5 M Urea 27 (3) 3,196 (79)
4 M GTCd 228 (29) 122 (3)
1% SDS 1,439 (182) 2,091 (51)
a cDNA-RNA hybridization signal intensity measured by laser densitome-
try (percent of blot intensity obtained with direct blotting of the same virus
sample). In each case, virus was 50 ,ul of gradient-purified HAV suspended in
0.1% bovine serum albumin; direct blotting of this material gave a blot
intensity of 787. The probe was whole plasmid pHAVLB148 (25).
b Residual HAV antigen bound to the solid-phase support after the elution
of virus detected with '251-anti-HAV (percent of total virus sample counts per
minute [4,066 cpm]).
c TCA, Trichloroacetic acid.
d GTC, Guanidinium thiocyanate.
be a reasonable alternative for use with other, acid-sensitive
picornaviruses.
The sensitivity of the combined immunoaffinity hybridiza-
tion procedure was compared with that of direct blotting of
virus present in dilutions made from both gradient-purified
virus (Fig. 1, lanes A and B) and a positive human fecal
suspension (Fig. 1, lanes D and E). These two procedures
gave comparable results in terms of the highest dilutions at
which viral RNA could be detected, although hybridization
signal intensities were somewhat greater with the direct
blotting method at the highest dilutions. In terms of virus
titer determined by endpoint dilution, both hybridization
procedures were 10- to 30-fold more sensitive than a con-
ventional solid-phase radioimmunoassay (15) or a similar
assay incorporating a monoclonal antibody (K3-2F2) for
antigen capture (Table 2). The difference between the im-
munoassay and hybridization methods was less impressive
with the crude fecal suspension than with gradient purified
virus, possibly owing to the presence of viral antigen that
was not associated with RNA in the fecal specimen.
Despite the fact that comparable endpoint titers were
obtained when the direct blotting and immunoaffinity hybrid-
ization methods were applied to the specimens shown in Fig.
1, there was a substantial difference in the blot intensities at
TABLE 2. Sensitivity of direct blot, immunoaffinity
hybridization, and solid-phase immunoassays for
detection of HAV
Loglo endpoint titer with:
Method Purified Fecal
HAVa ~~specimenHAVa GR8a
Immunoaffinity hybridizationb >4.0 3.5
Direct blot, hybridization >4.0 3.5
RNA blot, hybridization 3.0 2.0
Solid-phase radioimmunoassay
Monoclonal capture antibody 3.0 3.0
Polyclonal capture antibody 2.5 3.0
a Purified HAV was estimated to contain 4 x 109 genome copies per ml,
whereas fecal specimen GR8 contained about 4 x 108 genome copies per ml.
b The probe was 1307-1; autoradiograph exposure time was 72 h.
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FIG. 2. Specificity of the cDNA probe and the immunoaffinity
hybridization procedure for HAV. Slots A and B represent DNA-
DNA hybridization in which DNA from 2 x 107 E. coli cells was
immobilized on nitrocellulose and hybridized with the HAV insert
probe. (A) E. coli containing plasmid pBR322. (B) E. coli containing
the related plasmid pHAVLB1307 (25). Slots C to E represent
immunoaffinity hybridization blots of a normal, virus-negative fecal
specimen spiked with 8 x 10' (C), 4 x 101 (D), or 2 x 109 (E) CFU
of E. coli containing pHAVLB1307 per ml. Slot F is a direct blot of
cell culture supernatant containing approximately 104 radioim-
munofocus-forming units of cell culture-adapted HAV (12). The
probe was 1307-1; autoradiographs were exposed for 72 h.
the lowest dilution of the fecal specimen. At this dilution, at
which the concentration of fecal contaminants is maximal,
significantly greater blot intensity was achieved with the
immunoaffinity procedure than with direct blotting (Fig. 1,
lanes D and E; 0.5 log dilution). This difference was not
evident when the applied virus was first gradient purified
(Fig. 1, lanes A and B). The reduced signal achieved with
direct blotting of the concentrated fecal specimen was in part
due to difficulties encountered in filtering it through the
nitrocellulose but possibly was also related to contaminating
proteins or nucleic acids or both interfering with the binding
of filtered virus to the nitrocellulose. Together, these results
suggest that the immunoaffinity hybridization procedure may
be especially useful for fecal specimens containing amounts
of virus that are too low to be detectable by direct blotting
after the sample has been diluted to a point at which filtration
may be efficiently accomplished.
Specificity of immunoaffinity hybridization. An important
advantage of the immunoaffinity hybridization procedure
over direct blotting or more conventional approaches to the
detection of virus by nucleic acid hybridization is the poten-
tial for enhanced specificity afforded by the monoclonal
capture antibody. To assess the role played by the capture
antibody in determining the specificity of the assay method,
the monoclonal antibody coating the solid phase was re-
placed with an equal amount of murine monoclonal antibody
directed against an unrelated antigen (mycoplasma) or car-
bonate buffer alone. Both modifications resulted in the
complete elimination of the hybridization signal achieved
with samples containing HAV (data not shown). To further
assess specificity, a human fecal specimen that did not
contain detectable HAV nucleic acid or antigen was spiked
with a suspension of E. coli cells containing the plasmid
pHAVLB1307 (pBR322 with a 2.8-kilobase HAV cDNA
insert at the PstI site) (25). This mixture was subjected to
immunoaffinity hybridization, using probe 1307-1 (Fig. 2,
slots C to E). As an additional control, a second sample of
the fecal suspension was spiked with an equal amount of E.
coli containing pBR322 (with no HAV insert) and tested in a
similar fashion. In these experiments, the addition of 2 x 109
CFU of either bacterial strain per ml to the normal fecal
suspension did not result in a positive hybridization signal,
confirming a high degree of specificity conferred by the
immunoaffinity step. When DNA was extracted from both
strains of E. coli (2 x 107 CFU) and subjected to slot blotting
and hybridization with the HAV probe, only DNA from the
bacterial strain containing plasmid pHAVLB1307 evoked a
positive hybridization response (Fig. 2, slots A and B). This
result indicated that the HAV cDNA probe had a high degree
of specificity for HAV relative to pBR322 sequences. Thus,
the overall immunoaffinity hybridization procedure had
specificity conferred at two levels, the first being the mono-
clonal capture antibody and the second being the probe
itself.
Detection of HAV RNA in human fecal specimens. Positive
results were obtained with the immunoaffinity hybridization
procedure when it was applied to known positive fecal
specimens containing either strain MS-1 (4) or strain HM-175
(11) of the virus. In addition, virus was detected by this
method in fecal specimens obtained from two recent out-
breaks of hepatitis A, one of which occurred in North
America and the other of which occurred in Europe (10).
Thus, the combination of the monoclonal antibody and
probe used in the procedure appears broadly reactive with a
number of HAV strains. This is not surprising given the
conditions of selection of the monoclonal antibody (17) and
the degree of conservation apparent in the nucleotide se-
quence of several different HAV strains (2, 16, 19).
Immunoaffinity hybridization was compared with the sol-
id-phase radioimmunoassay for detection of HAV in fecal
specimens collected during week 1 of illness from 23 men
experiencing acute hepatitis A (10) (Table 3). Of these 23
TABLE 3. Comparison of immunoaffinity hybridization and solid-
phase radioimmunoassay for detection of HAV in human
fecal samples











GR2 45 1.9 (-)
GR17 17 5.9
GR9 1 2.2
GR18 1 1.8 (-)
GR17 +/_c 1.0 (-)
GR21 +/- 2.0 (-)
Hybridization negative
GR3 - 1.4(-)
GR10 - 1.1 (-)
GR11 - 1.1(-)
GR12 - 1.1 (-)
GR13 - 0.8 (-)
GR16 - 1.7 (-)
GR23 - 0.8 (-)
GR24 - 1.0 (-)
a The probe was 228; autoradiograph exposure time was 8 days.
b P/N ratio, Positive/negative ratio.
C +/-, Not reproducibly positive on repeat testing.
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fecal specimens, 13 were reproducibly positive for HAV
RNA by the hybridization method, whereas 2 others gave
weakly positive results that were not confirmed on repeat
testing. Two of the 13 reproducibly positive specimens and
both of the questionably positive specimens were negative
for HAV antigen by radioimmunoassay. Whereas the most
intense hybridization signal was generally found with those
specimens having the highest radioimmunoassay posi-
tive/negative values (highest antigen content), exceptions
were noted in both directions (Table 3).
To confirm the specificity of the hybridization results,
fecal specimens were tested by immunoaffinity hybridization
by using both anti-HAV and an unrelated murine monoclo-
nal antibody immobilized on the solid phase as capture
antibodies; positive hybridization signals occurred only with
the anti-HAV monoclonal antibody (Fig. 3).
For the sake of comparison, we attempted to directly blot
the fecal suspensions. Substantial problems were encoun-
tered in accomplishing the filtration of sufficient quantities of
these suspensions, owing to their high protein content.
Although it was possible to subject 100 ,ul of each fecal
suspension to testing by the immunoaffinity hybridization
method, with 5 of the 23 specimens we were unable to
completely filter 10 ,ul of a 20% suspension (even after
dilution in 200 ,ul of blotting buffer). Five other specimens
were successfully filtered only after an extended period, and
only 6 of the 23 original specimens gave positive hybridiza-
tion results with this approach (compared with 13 that were
positive by immunoaffinity hybridization). Not surprisingly,
these six positive specimens were those that were most
strongly positive in the immunoaffinity hybridization assay
(GR15, GR8, GR7, GR19, GR5, and GR6; Table 3). It is
important to note that the greater sensitivity of the im-
munoaffinity hybridization method, when compared with the












FIG. 3. Immunoaffinity hybridization of HAV present in suspen-
sions of 10 human fecal specimens collected during week 1 of
symptoms due to hepatitis A (10). Lane A, Blots of eluates from
control microtiter plate wells coated with a murine monoclonal
antibody to an unrelated, mycoplasmal antigen; lane B, blots of
eluates from microtiter plate wells coated with the anti-HAV
monoclone K3-2F2 (17). The probe was 1307-2; autoradiographs
were exposed for 8 days.
the fact that the method makes possible the testing of a larger
volume of the stool suspension.
DISCUSSION
The recent molecular cloning of the HAV genome (16, 19,
25) provided important new reagents that now permit the
detection of this virus in cell culture samples as well as
clinical specimens by cDNA-RNA hybridization (21). How-
ever, the successful detection of viral nucleic acid by hybrid-
ization has previously entailed multiple manipulations of
individual specimens, and we therefore sought to develop a
simplified approach that would facilitate the application of
cDNA-RNA hybridization to many specimens.
In comparing different methods for blotting HAV to nitro-
cellulose for subsequent detection by cDNA-RNA hybrid-
ization, we found that the direct application of virus sus-
pended in a 7.5 x SSC-4.2 M formaldehyde buffer resulted
in a higher level of sensitivity than the blotting of RNA
extracted from samples by a procedure involving SDS dena-
turation, proteinase K digestion, and extraction with organic
solvents (Fig. 1). We suspect that under the conditions used
for direct blotting, virions attached to the nitrocellulose are
disrupted with the release of RNA onto the nitrocellulose
during the baking of the paper. The greater sensitivity of the
direct blotting method, compared with the blotting of chem-
ically extracted RNA (Fig. 1), may be related either to the
more efficient binding of virus to the nitrocellulose or to the
physical loss or degradation of RNA during the extraction
procedure. Regarding this latter possibility, preliminary ex-
periments involving the extraction of RNA from virions that
were intrinsically labeled with [3H]uridine have suggested
that at least 50% of the virion RNA is recovered as acid-
precipitable material. Previous investigators have noted the
feasibility of directly blotting picornaviruses present in cell
culture lysates to nylon membrane filters (23), and this may
be a general attribute of this group of viruses. We used
nitrocellulose exclusively for the experiments described in
this paper. More recent experiments suggest that, whereas
nylon filters such as Nytran (Schleicher & Schuell) and
Biodyne (ICN Biomedicals, Inc., Irvine, Calif.) may be
substituted for nitrocellulose paper in the immunoaffinity
hybridization procedure, they may be less efficient in binding
intact virions.
Although we have found the direct blotting of virus to be
extremely useful in monitoring the release of HAV into cell
culture supernatant fluids or in tracking virus during purifi-
cation procedures (14), it is not generally applicable to
clinical specimens, owing to the frequent presence of large
amounts of contaminating materials that interfere with the
blotting process. We therefore developed a combined im-
munoaffinity hybridization method in an effort to arrive at a
simple and practical yet sensitive method of applying cDNA
hybridization to the detection of HAV in clinical materials.
The new method offers significantly greater sensitivity than
the conventional solid-phase radioimmunoassay for the de-
tection of HAV in fecal specimens collected from acutely
infected individuals (Tables 2 and 3). This added sensitivity
was achieved with a minimum increase in the number of
manipulations for each specimen. In addition, specificity
problems that may be encountered in detecting viral nucleic
acids in grossly contaminated specimens (1, 5) have been
largely overcome by the combined use of highly purified
insert probes and the incorporation of a simple solid-phase
immunoaffinity purification step before the immobilization of
the viral RNA. This additional step significantly enhances
the specificity of the hybridization assay (without substan-
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tially reducing sensitivity) and permits positive hybridization
signals to be related to specific antigens (Fig. 3). At the same
time, the immunoaffinity step efficiently removes most con-
taminating proteins and results in the suspension of HAV
particles in a medium that permits their direct blotting to
nitrocellulose.
The specific immunoaffinity hybridization procedure we
developed for the detection of HAV was intended for use in
the research laboratory and is likely to prove useful in future
studies of the pathogenesis of hepatitis A in naturally in-
fected humans or experimentally infected nonhuman pri-
mates. It is unlikely that any application in the clinical
diagnostic laboratory will be found, as the diagnosis of acute
hepatitis A is made more rapidly and with greater ease and
sensitivity by the detection of virus-specific immunoglobulin
M antibodies (6, 13). Nonetheless, with appropriate modifi-
cations, the method described in this paper should prove
generally applicable to other picornaviruses, including other
enteroviruses. Antigenically distinct enteroviruses may
share extensive nucleic acid homology, both at the 5' end of
the genome in regions outside the open reading frame and
within the 3' region of the genome which encodes the RNA
polymerase (2, 9, 23). This shared homology has been
exploited by the successful use of poliovirus and coxsackie-
virus B cDNA probes for the detection of antigenically
unrelated enteroviruses in cell culture (9, 23). The inclusion
of a simple immunoaffinity step, such as that described in
this paper, before the immobilization of the virus for hybrid-
ization would provide a rapid means of establishing the
immunologic identity of viruses detected with any of several
different probes and could result in substantially improved
methods for the detection of picornaviruses in clinical ma-
terials. Such an approach would permit the serotyping of
enteroviruses and, potentially, the distinction of vaccine
strain and wild-type polioviruses at a level of sensitivity
offered only by cDNA hybridization.
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